These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16741581)
21. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938 [TBL] [Abstract][Full Text] [Related]
22. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. McCrimmon RJ; Fan X; Ding Y; Zhu W; Jacob RJ; Sherwin RS Diabetes; 2004 Aug; 53(8):1953-8. PubMed ID: 15277372 [TBL] [Abstract][Full Text] [Related]
23. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress. Huang Q; Timofeeva E; Richard D J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401 [TBL] [Abstract][Full Text] [Related]
24. Repeated Activation of Noradrenergic Receptors in the Ventromedial Hypothalamus Suppresses the Response to Hypoglycemia. Sejling AS; Wang P; Zhu W; Farhat R; Knight N; Appadurai D; Chan O Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33367607 [TBL] [Abstract][Full Text] [Related]
25. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029 [TBL] [Abstract][Full Text] [Related]
26. Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue. Chao H; Digruccio M; Chen P; Li C Endocrinology; 2012 Jan; 153(1):166-76. PubMed ID: 22067315 [TBL] [Abstract][Full Text] [Related]
27. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Paranjape SA; Chan O; Zhu W; Horblitt AM; McNay EC; Cresswell JA; Bogan JS; McCrimmon RJ; Sherwin RS Diabetes; 2010 Jun; 59(6):1521-7. PubMed ID: 20299468 [TBL] [Abstract][Full Text] [Related]
28. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. Li C; Vaughan J; Sawchenko PE; Vale WW J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127 [TBL] [Abstract][Full Text] [Related]
29. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117 [TBL] [Abstract][Full Text] [Related]
30. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Levin BE; Becker TC; Eiki J; Zhang BB; Dunn-Meynell AA Diabetes; 2008 May; 57(5):1371-9. PubMed ID: 18292346 [TBL] [Abstract][Full Text] [Related]
31. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure. Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421 [TBL] [Abstract][Full Text] [Related]
32. The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response. Dedic N; Chen A; Deussing JM Curr Mol Pharmacol; 2018; 11(1):4-31. PubMed ID: 28260504 [TBL] [Abstract][Full Text] [Related]
33. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Borg MA; Borg WP; Tamborlane WV; Brines ML; Shulman GI; Sherwin RS Diabetes; 1999 Mar; 48(3):584-7. PubMed ID: 10078560 [TBL] [Abstract][Full Text] [Related]
34. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Li C; Chen P; Vaughan J; Blount A; Chen A; Jamieson PM; Rivier J; Smith MS; Vale W Endocrinology; 2003 Jul; 144(7):3216-24. PubMed ID: 12810578 [TBL] [Abstract][Full Text] [Related]
35. Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia. Flanagan DE; Keshavarz T; Evans ML; Flanagan S; Fan X; Jacob RJ; Sherwin RS Diabetes; 2003 Mar; 52(3):605-13. PubMed ID: 12606499 [TBL] [Abstract][Full Text] [Related]
36. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Liaw CW; Grigoriadis DE; Lorang MT; De Souza EB; Maki RA Mol Endocrinol; 1997 Dec; 11(13):2048-53. PubMed ID: 9415408 [TBL] [Abstract][Full Text] [Related]
37. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255 [TBL] [Abstract][Full Text] [Related]
38. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Evans ML; McCrimmon RJ; Flanagan DE; Keshavarz T; Fan X; McNay EC; Jacob RJ; Sherwin RS Diabetes; 2004 Oct; 53(10):2542-51. PubMed ID: 15448082 [TBL] [Abstract][Full Text] [Related]
39. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308 [TBL] [Abstract][Full Text] [Related]
40. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. de Vries MG; Arseneau LM; Lawson ME; Beverly JL Diabetes; 2003 Nov; 52(11):2767-73. PubMed ID: 14578295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]